MENU
NVCT
AS OF
Feb 4, 04:12 PM (EDT)
Price
$8.28
Change
-$0.21 (-2.48%)
Capitalization
217.21M
34 days until earnings call
Intraday BUY SELL Signals
+Compare
NVCT
Stock ticker: NASDAQ
AS OF
Feb 4, 04:12 PM (EDT)
Price
$8.28
Change
-$0.21 (-2.48%)
Capitalization
217.21M

NVCT Nuvectis Pharma Forecast, Technical & Fundamental Analysis

Nuvectis Pharma Inc is a biopharmaceutical company... Show more

NVCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVCT with price predictions
Feb 03, 2026

NVCT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for NVCT moved above the 200-day moving average on January 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 48 cases where NVCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on NVCT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVCT advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 103 cases where NVCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NVCT moved out of overbought territory on January 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for NVCT turned negative on January 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVCT broke above its upper Bollinger Band on January 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.050) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NVCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVCT is expected to report earnings to fall 42.27% to -25 cents per share on March 10

Nuvectis Pharma NVCT Stock Earnings Reports
Q4'25
Est.
$-0.25
Q3'25
Missed
by $0.19
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 3.58K shares outstanding, the current market capitalization sits at 217.21M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Bridge Plaza
Phone
+1 201 614-3150
Employees
13
Web
https://www.nuvectis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AICOF0.110.01
+8.70%
Generative AI Solutions Corp.
CFPZF10.900.33
+3.08%
Canfor Corp.
JUKIY3.11N/A
N/A
Juki Corp.
GGDVY45.26N/A
N/A
Guangdong Investment Ltd.
AONNY13.85-0.20
-1.42%
Aeon Co. Ltd.

NVCT and Stocks

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+1.44%
PDSB - NVCT
33%
Poorly correlated
-7.41%
IMVT - NVCT
32%
Poorly correlated
-1.07%
MRVI - NVCT
31%
Poorly correlated
-3.26%
RNAC - NVCT
31%
Poorly correlated
+2.06%
GLMD - NVCT
30%
Poorly correlated
+0.69%
More